Featured Research

from universities, journals, and other organizations

Vaccine risk to myasthenia gravis patients may be worth taking

Date:
October 16, 2013
Source:
American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)
Summary:
First step taken in collection of data on vaccine-preventable illnesses in patients with myasthenia gravis, a neuromuscular disorder causing weakness and rapid fatigue of voluntary muscles.

A study presented at the annual meeting of the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) is considered a good first step in collecting data on vaccine-preventable illnesses in patients with myasthenia gravis, a neuromuscular disorder causing weakness and rapid fatigue of voluntary muscles.

"This research is important because there is very little existing data to guide physicians in recommending vaccination for patients with myasthenia gravis," said Andrew Tarulli, MD, AANEM News Science Editorial Board member.

"Physicians, particularly primary care physicians, may undervaccinate their myasthenic patients because they may be concerned about the possibility of provoking an exacerbation. On the contrary, failure to vaccinate a patient may result in pneumonia or influenza, both of which are common precipitants of myasthenia exacerbations or even myasthenic crises," said Dr. Tarulli.

The AANEM committee members reviewing the research agreed that it is a good first step in collecting data on vaccine-preventable illnesses and should be followed by studies documenting the safety of vaccination conducted in larger cohorts. The ultimate goal would be to produce a set of guidelines for neuromuscular physicians who treat myasthenics.

The study, entitled, Prevalence of Vaccine Preventable Infections in Myasthenia Gravis and its Exacerbations, was conducted by Crystal Dixon, MD, a neurology resident at the University of South Florida. Dr. Dixon received the Best Abstract Runner-Up award from the AANEM for her research.


Story Source:

The above story is based on materials provided by American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Note: Materials may be edited for content and length.


Cite This Page:

American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). "Vaccine risk to myasthenia gravis patients may be worth taking." ScienceDaily. ScienceDaily, 16 October 2013. <www.sciencedaily.com/releases/2013/10/131016095734.htm>.
American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). (2013, October 16). Vaccine risk to myasthenia gravis patients may be worth taking. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2013/10/131016095734.htm
American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). "Vaccine risk to myasthenia gravis patients may be worth taking." ScienceDaily. www.sciencedaily.com/releases/2013/10/131016095734.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Fauci: Ebola Protocols to Focus on Training

Fauci: Ebola Protocols to Focus on Training

AP (Oct. 20, 2014) Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, says he expects revised CDC protocols on Ebola to focus on training, observation and ensuring health care workers are more protected. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins